XML 23 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Ordinary Shares
Additional Paid-in Capital
Treasury Shares
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Total Equity of Capri
Non-controlling Interests
Beginning balance at Apr. 02, 2016 $ 1,999 $ 0 $ 719 $ (1,650) $ (81) $ 3,007 $ 1,995 $ 4
Beginning balance (in shares) at Apr. 02, 2016   208,084,000            
Beginning balance (in shares) at Apr. 02, 2016       (31,642,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 552         553 553 (1)
Other comprehensive income 0       0   0 0
Comprehensive income 552           553 (1)
Vesting of restricted awards, net of forfeitures (in shares)   454,000            
Exercise of employee share options 8   8       8  
Exercise of employee share options (in shares)   794,000            
Equity compensation expense 34   34       34  
Tax benefits on exercise of share options 7   7       7  
Purchase of treasury shares (1,005)     $ (1,005)     (1,005)  
Purchase of treasury shares (in shares)       (21,857,000)        
Ending balance (in shares) at Apr. 01, 2017       (53,499,000)        
Ending balance (in shares) at Apr. 01, 2017   209,332,000            
Ending balance at Apr. 01, 2017 1,595 $ 0 768 $ (2,655) (81) 3,560 1,592 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 592         592 592 0
Other comprehensive income 132       132   132 0
Comprehensive income 724           724 0
Increase in noncontrolling interest 3             3
Partial repurchase of non-controlling interest (1)             (1)
Vesting of restricted awards, net of forfeitures (in shares)   542,000            
Exercise of employee share options 14   14       14  
Exercise of employee share options (in shares)   1,117,000            
Equity compensation expense 50   50       50  
Purchase of treasury shares (361)     $ (361)     (361)  
Purchase of treasury shares (in shares)       (7,794,000)        
Redemption of capital/dividends (1)             (1)
Other $ (1)   (1)       (1)  
Ending balance (in shares) at Mar. 31, 2018 (61,292,684)     (61,293,000)        
Ending balance (in shares) at Mar. 31, 2018 210,991,091 210,991,000            
Ending balance at Mar. 31, 2018 $ 2,022 $ 0 831 $ (3,016) 51 4,152 2,018 4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Adoption of accounting standards (See Note 2) 12         12 12  
Balance as of April 1, 2018 2,034   831 (3,016) 51 4,164 2,030 4
Net income (loss) 542         543 543 (1)
Other comprehensive income (117)       (117)   (117) 0
Comprehensive income 425           426 (1)
Issuance of ordinary shares (in shares)   2,395,000            
Issuance of ordinary shares 91   91       91  
Increase in noncontrolling interest 0              
Vesting of restricted awards, net of forfeitures (in shares)   818,000            
Exercise of employee share options 29   29       29  
Exercise of employee share options (in shares)   1,847,000            
Equity compensation expense 60   60       60  
Purchase of treasury shares (207)     $ (207)     (207)  
Purchase of treasury shares (in shares)       (3,826,000)        
Other $ 0              
Ending balance (in shares) at Mar. 30, 2019 (65,118,633)     (65,119,000)        
Ending balance (in shares) at Mar. 30, 2019 216,050,939 216,051,000            
Ending balance at Mar. 30, 2019 $ 2,432 $ 0 $ 1,011 $ (3,223) $ (66) $ 4,707 $ 2,429 $ 3